PMID- 25299503
OWN - NLM
STAT- MEDLINE
DCOM- 20160805
LR  - 20221207
IS  - 1898-018X (Electronic)
IS  - 1898-018X (Linking)
VI  - 22
IP  - 2
DP  - 2015
TI  - Cardiovascular risk management in type 2 diabetes of more than 10-year duration: 
      Results of Polish ARETAEUS2-Grupa Study.
PG  - 150-9
LID - 10.5603/CJ.a2014.0067 [doi]
AB  - BACKGROUND: ARETAEUS 1 study showed that a great majority of patients with type 2 
      diabetes mellitus (T2DM) of short duration did not meet all of the treatment 
      goals. Since then the treatment goals in T2DM have been changed. The aim of the 
      ARETAEUS 2-Grupa Study was to assess cardiovascular (CV) risk management and 
      meeting treatment goals in the population of T2DM of more than 10-year duration. 
      METHODS: ARETAEUS2-Grupa was a cross-sectional questionnaire-based study 
      conducted in Poland in 2012. Randomly selected physicians recruited 1,740 
      patients with T2DM diagnosed more than 10 years before the study. RESULTS: Lipid 
      treatment goals were met respectively: for total cholesterol in 34.5% of all 
      patients, triglycerides in 53.8%, low density lipoprotein cholesterol (LDL-C) in 
      26.5% and high density lipoprotein cholesterol (HDL-C) in 38.2%. Most of patients 
      with and without coronary artery disease were receiving aspirin (90.3% and 60%, 
      respectively) and statins (84.4% and 67.7%, respectively). The current blood 
      pressure (BP) goal (140/90 mm Hg) was met in 43.5% of patients and the previous 
      goal (< 130/80 mm Hg) in 12.4%. The patients were mainly treated with >/= 3 
      antihypertensive drugs. All treatment goals (for HbA1c, BP and LDL-C) were 
      reached only by 8.2% of patients, any two goals by 26.3% of patients, one goal by 
      39.8% of patients, none by 25.6% of patients. CONCLUSIONS: The new less 
      restrictive treatment goals are reached more frequently but still much is to be 
      done in the field of clinical practice guidelines implementation and CV 
      prevention in T2DM population.
FAU - Lesniak, Wiktoria
AU  - Lesniak W
AD  - 2nd Department of Inter nal Medicine, Jagiellonian Univer sity Medical College, 
      Krakow, Poland. lesniak@mp.pl.
FAU - Bala, Malgorzata M
AU  - Bala MM
FAU - Placzkiewicz-Jankowska, Ewa
AU  - Placzkiewicz-Jankowska E
FAU - Topor-Madry, Roman
AU  - Topor-Madry R
FAU - Jankowski, Milosz
AU  - Jankowski M
FAU - Sieradzki, Jacek
AU  - Sieradzki J
FAU - Banasiak, Waldemar
AU  - Banasiak W
CN  - ARETAEUS2 Study Group
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
DEP - 20141009
PL  - Poland
TA  - Cardiol J
JT  - Cardiology journal
JID - 101392712
RN  - 0 (Antihypertensive Agents)
RN  - 0 (Biomarkers)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (Hydroxymethylglutaryl-CoA Reductase Inhibitors)
RN  - 0 (Hypoglycemic Agents)
RN  - 0 (Lipids)
RN  - 0 (Platelet Aggregation Inhibitors)
RN  - 0 (hemoglobin A1c protein, human)
SB  - IM
MH  - Aged
MH  - Antihypertensive Agents/*therapeutic use
MH  - Biomarkers/blood
MH  - Blood Pressure/drug effects
MH  - Cardiovascular Diseases/diagnosis/epidemiology/*prevention & control
MH  - Coronary Artery Disease/diagnosis/*drug therapy/epidemiology
MH  - Cross-Sectional Studies
MH  - Diabetes Mellitus, Type 2/blood/diagnosis/*drug therapy/epidemiology
MH  - Female
MH  - Glycated Hemoglobin/metabolism
MH  - Guideline Adherence
MH  - Health Care Surveys
MH  - Humans
MH  - Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use
MH  - Hyperlipidemias/blood/diagnosis/*drug therapy/epidemiology
MH  - Hypertension/diagnosis/*drug therapy/epidemiology/physiopathology
MH  - Hypoglycemic Agents/*therapeutic use
MH  - Lipids/blood
MH  - Male
MH  - Middle Aged
MH  - Platelet Aggregation Inhibitors/*therapeutic use
MH  - Poland/epidemiology
MH  - Practice Guidelines as Topic
MH  - Practice Patterns, Physicians'
MH  - Risk Assessment
MH  - Risk Factors
MH  - Surveys and Questionnaires
MH  - Time Factors
MH  - Treatment Outcome
FIR - Sieradzki, Jacek
IR  - Sieradzki J
FIR - Banasiak, Waldemar
IR  - Banasiak W
FIR - Czupryniak, Leszek
IR  - Czupryniak L
FIR - Gorska, Maria
IR  - Gorska M
FIR - Grzeszczak, Wladyslaw
IR  - Grzeszczak W
FIR - Malecki, Maciej
IR  - Malecki M
FIR - Wierusz-Wysocka, Bogna
IR  - Wierusz-Wysocka B
EDAT- 2014/10/10 06:00
MHDA- 2016/08/06 06:00
CRDT- 2014/10/10 06:00
PHST- 2014/05/20 00:00 [received]
PHST- 2014/08/22 00:00 [accepted]
PHST- 2014/08/19 00:00 [revised]
PHST- 2014/10/10 06:00 [entrez]
PHST- 2014/10/10 06:00 [pubmed]
PHST- 2016/08/06 06:00 [medline]
AID - VM/OJS/J/38313 [pii]
AID - 10.5603/CJ.a2014.0067 [doi]
PST - ppublish
SO  - Cardiol J. 2015;22(2):150-9. doi: 10.5603/CJ.a2014.0067. Epub 2014 Oct 9.